STAT

MARCH 10, 2024

Medicare announced on Saturday that it will make advance payments available to physician groups, hospitals, and other health care facilities as part of its response to the February 21 Change Healthcare cyberattack. The payments are meant to fund providers that aren’t able to submit claims to Medicare because of the disruption to Change’s data network and have exhausted all other potential avenues of funding.

Hospitals 140

Hospitals Insurance 140

The Guardian - Pharmaceutical Industry

MARCH 10, 2024

Confronted by the huge salaries on offer in the US, London boardrooms are lobbying to be allowed to make their own bosses even wealthier There was a sharp intake of breath last month when the pharmaceuticals group AstraZeneca cemented chief executive Pascal Soriot’s position as the best-paid FTSE 100 boss with a £17m pay package , up from £15.3m a year earlier.

Packaging 131

Packaging 131

Fierce Healthcare

MARCH 10, 2024

LAS VEGAS — Francisco Dizon, 77 years old, sat comfortably in his living room as a team of clinicians took his vital signs and administered IV medications to treat his urinary tract infection. | The American Medical Association and the American Telemedicine Association joined major health systems like Geisinger, John Hopkins and Mass General Brigham along with health tech companies to call for Congressional support for the future of home-based care.

Hospitals 131

Hospitals 131

Pharmacy Times

MARCH 10, 2024

In addition, the length of hospital admissions were greater in patients with hidradenitis suppurativa-associated cutaneous squamous cell carcinoma compared to other admissions.

Hospitals 123

Hospitals 123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

MARCH 10, 2024

The FDA has said it will seek the advice of independent advisors before it concludes its review of Eli Lilly’s amyloid-targeting Alzheimer’s disease therapy donanemab, delaying its review of the drug. Lilly said the US regulator “wants to further understand topics related to evaluating the safety and efficacy of donanemab,” which includes the safety and efficacy results of its pivotal TRAILBLAZER-ALZ 2 study.

FDA 124

FDA 124

Fierce Healthcare

MARCH 10, 2024

ORLANDO, Florida—The industry continues to make substantial gains in health data exchange and interoperability, according to new data released by health information network Surescripts. | ORLANDO, Florida—The industry continues to make substantial gains in health data exchange and interoperability, according to new data released by health information network Surescripts.

119

119

The Checkup by Singlecare

MARCH 10, 2024

For many people, Wegovy has been a helpful tool in the journey toward weight loss. Wegovy, developed by Novo Nordisk, is an injectable medication containing semaglutide. It works as a GLP-1 receptor agonist by mimicking a hormone that regulates appetite, leading to reduced hunger and food intake. Approved by the Food and Drug Administration (FDA) for individuals with obesity or who are overweight with at least one weight-related problem, Wegovy pens are typically prescribed alongside a healthy d

Dosage 98

Dosage Packaging FDA 98

The FDA Law Blog

MARCH 10, 2024

Last August the Food and Drug Administration (“FDA”)/Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule cannabis from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. By doing so, FDA/HHS believe that cannabis no longer meets schedule I criteria but does not meet schedule II criteria either.

Controlled Substances 64

Controlled Substances FDA 64

Med Ed 101

MARCH 10, 2024

For individuals with type 2 diabetes taking insulin, managing doses is a critical aspect of their treatment regimen. Proper management of insulin doses can help maintain blood sugar levels within a healthy range and prevent complications associated with high or low blood sugar. However, determining how much to increase or decrease insulin doses can be […] The post Managing Insulin in Type 2 Diabetes appeared first on Med Ed 101.

52

52

PharmExec

MARCH 10, 2024

Sales and marketing effectiveness of speaker programs is often one of the least understood aspects in the industry. Yet, pharma brands spent over $12.5 billion in 2022 to engage and influence with HCP-to-HCP activities. CMS’s Open Payments data is an overlooked tool to get greater visibility and create more strategic opportunities—while also enriching compliance.

40

40

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA